Comparison Of The Effects Of Ivermectin, Permethrin & Gamma Benzene Hexachloride Alone And With That Of Combination Therapy For The Management Of Scabies. Effect and Safety of Scabicidal drugs

Main Article Content

Saborni Dey
Sachin Agarwal


Permethrin & Ivermectin efficacy



The present study compared three scabicidal agents alone or with combination - the currently considered medicine of choice permethrin, oral ivermectin and gamma benzene hexachloride in the local population of India.

A total of 120 patients were enrolled and randomly divided into 4 groups. Group A received topical 5% permethrin & oral placebo, Group B was given topical placebo cream & oral ivermectin in two dose regimen. Group C received topical 1% gamma benzene hexachloride with oral placebo & Group D was given topical 5% permethrin & oral ivermectin. The improvement of lesions & pruritus were assessed in the next 3 follow ups i.e. at the 7th day, 14th day, & 28th day along with any adverse drug reactions (ADRs).

Group A had 83%, 90%, 97% while Group B had 70%, 81% & 91% improvement of lesions in 3 follow ups. Group C showed 57%, 70%, 86% and Group D had 82%, 90%, 97% efficiency to decrease lesion count.(p>0.05) Again Group A observed 77%, 88%, 94% improvement in pruritus in subsequent follow ups, while for Group B it was 63%, 76% & 86%. Group C had 55%, 71%, 85% efficiency and Group D had recorded 77%, 88% & 94% improvement to decrease pruritus.(p>0.05) The incidence of adverse effects was found to be less in Group B, Group C & Group D when compared to Group A. 

Conclusion : Group D or combination therapy was a better choice for scabies in comparison to other monotherapy due to its better efficacy and safety profile.

 Keywords : Scabies, permethrin, ivermectin, gamma benzene hexachloride.

Abstract 259 | PDF Downloads 181 XML Downloads 86 HTML Downloads 117


1. Karthikeyan K. Treatment of scabies: Newer perspectives. Postgrad Med J 2005; 81:7-11.
2. Lee B, Groth P. Scabies: transcutaneous poisoning during treatment. Pediatrics dermatol 1977; 59:643.
3. Davies JE, Dadhia HW, Morgade C, Barquet A, Maibach HI. Gamma benzene hexachloride Poisoning. Arch Dermatol 1983; 119:142-44.
4. Zargari O, Golchai J, Sobhani A, Dehpour AR, Sadr-Ashkevari S, Alizadeh N et al., Comparison of the efficacy of topical 1% gamma benzene hexachloride vs 5% permethrin in scabies: A randomized, double-blind study. Indian J Dermatol Venerol Leprol 2006; 72:33-6.
5. Roth WI. Scabies resistant to lindane 1% lotion and crotamiton 10% cream. J. of the American Acad. of Dermatol 1991; 24(3):502– 503.
6. Delmar SM, McKinster CD, Orozco CL. Treatment of 18 children with scabies or cutaneous larva migrans using ivermectin. Clin Exp Dermatol 2002; 27: 264–7.
7. Sharma R, Singhal A. Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study. Indian Journal of Dermatology, Venereology and Leprology 2011; 77:581-6.
8. Macotela-Ruíz E, Peña-González G. The treatment of scabies with oral ivermectin. Gac Med Mex 1993; 129:201-5.
9. Usha V, Gopalakrishnan TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000; 42:236-40.
10. Bachewar NP, Thawani VR, Mali SN, Gharpure KJ, Shingade VP, Dakhale GN et al. Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies. Indian J Pharmacol 2009; 41:9-16.
11. Chouela EN, Abeldaño AM, Pellerano G, La-Forgia M, Papale RM, Garsd A et al. Equivalent therapeutic efficacy and safety of ivermectin and gamma benzene hexachloride in the Treatment of Human Scabies. Arch Dermatol 1999; 135:651-5.
12. Scheinfeld N. Controlling scabies in institutional settings: A review of medications, treatment models, and implementation. Am J Clin Dermatol 2004; 5:31-7.
13. Sule HM, Thacher TD. Comparison of ivermectin and benzyl benzoate lotion for scabies in Nigerian patients. Am J Trop Med Hyg 2007; 76:392-5.
14. Victoria J, Trujillo R. Topical ivermectin: A new successful treatment for scabies. Pediatr Dermatol 2001; 18:63-5.
15. Madan V, Jaskiran K, Gupta U. Oral ivermectin in scabies patients: a comparison with 1% topical gamma benzene hexachloride lotion. J Dermatol 2001; 28:481-4.
16. Taplin D, Meinking TL, Chen JA, Sanchez R. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990; 7:67-73.
17. Schultz MW, Gomez M, Hansen RC, Mills J, Menter A, Rodgers H et al. Comparative study of 5% permethrin cream and 1% gamma benzene hexachloride lotion for the treatment of scabies. Arch Dermatol 1990; 126:167-70.
18. Bachewar NP, Thawani VR, Mali SN, Gharpure KJ, Shingade VP, Dakhale GN et al. Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies. Indian J Pharmacol 2009; 41:9-16.
19. Elgart ML. A risk benefits assessment of agents used in the treatment of scabies. Drug Safet 1996; 14:386-93.
20. Burkhart CG, Burkhart CN. Optimal treatment for scabies remains undetermined. J Am Acad Dermatol 2001; 45:637.
21. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997; 349: 1144 - 5.
22. Conti-Diaz IA. Treatment of human scabies with oral Ivermectin. Revista Instituto Medicina Tropical 1999; 41: 259-61.
23. Dourmishev AL. Efficacy and tolerance of oral Ivermectin in scabies. J European Dermatology 1998; 11: 247-51.